Peter Manser
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Peter Manser has a total of 41 co-authors. Here are the top co-authors by number of shared publications:
- Michael K. Fix
Division of Medical Radiation Physics and Department of Radiation Oncology, Inselspital, Bern University Hospital, and University of Bern, Bern, Switzerland, Freiburgstrasse 18, Bern, 3010, Switzerland
15 shared publications - Silvan Mueller
Division of Medical Radiation Physics and Department of Radiation Oncology, Inselspital, Bern University Hospital, and University of Bern, Freiburgstrasse 18, Bern, 3010, Switzerland
10 shared publications - Marco Stampanoni
PSI Center for Photon Science, Paul Scherrer Institute, 5232 Villigen PSI, Switzerland
9 shared publications Werner Volken
Division of Medical Radiation Physics and Department of Radiation Oncology, Inselspital, Bern University Hospital, and University of Bern, Bern, Switzerland, Freiburgstrasse 18, Bern, 3010, Switzerland
7 shared publications- Hannes A. Loebner
Division of Medical Radiation Physics and Department of Radiation Oncology, Inselspital, Bern University Hospital, and University of Bern, Bern, SWITZERLAND
6 shared publications - Gian Guyer
Institute of Radiation Physics, Lausanne University Hospital and Lausanne University, Switzerland
5 shared publications
Latest Publications
- Open Access
- 15 April 2026
- Published by IOP Publishing in Physics in Medicine & Biology
- Vol. 71 (9)
Robust optimized dynamic mixed-beam arc radiotherapy for left-sided breast radiotherapy under deep inspiration breath-hold variations
Background and Purpose: Dynamic mixed-beam arc radiotherapy (DYMBARC) combines intensity-modulated electron- and photon-arcs in order to reduce normal tissue dose compared to photon-only techniques while ensuring similar target coverage. For left-sided breast, deep inspiration breath-hold (DIBH) improves heart sparing and mitigates breathing motion. However, dose delivery uncertainties remain due to inter- and intra-breath-hold variations. We assess robustness and dosimetric plan quality of robust optimized (RO)-DYMBARC under DIBH variations with comparison to VMAT. Materials and Methods: Ten cases were created using the XCAT anthropomorphic phantom. NiftyReg was used to obtain deformation vector fields (DVFs) for DIBH variations. For each case, three plans were created: PTV-based VMAT, RO-VMAT, and RO-DYMBARC, prescribed 42.4 Gy to the target volume (PTV or CTV for RO plans). Robustness to DIBH variations was assessed by recalculating doses using the DVFs and deformable voxel geometry Monte Carlo simulations. Dosimetric endpoints for targets and organs at risk (OARs) were compared using Wilcoxon matched-pair signed-rank test (α=0.05). Results: RO-DYMBARC demonstrated significantly better OAR sparing compared to VMAT, with mean dose to heart and contralateral breast up to 1 Gy lower than PTV-based VMAT. Target coverage and robustness to DIBH variations were similar across all plans. For OARs, DIBH variations led to dose differences ≤ 0.1 Gy for all plans and endpoints compared to the nominal scenario. Conclusion: RO-DYMBARC provided superior dosimetric plan quality with similar robustness to DIBH variations compared to VMAT. The dosimetric advantage of RO-DYMBARC was maintained in the presence of DIBH variations.
- 15 April 2026
- Published by IOP Publishing in Physics in Medicine & Biology
- Vol. 71 (9)
Open AccessRobust optimized dynamic mixed-beam arc radiotherapy for left-sided breast radiotherapy under deep inspiration breath-hold variations
Background and Purpose: Dynamic mixed-beam arc radiotherapy (DYMBARC) combines intensity-modulated electron- and photon-arcs in order to reduce normal tissue dose compared to photon-only techniques while ensuring similar target coverage. For left-sided breast, deep inspiration breath-hold (DIBH) improves heart sparing and mitigates breathing motion. However, dose delivery uncertainties remain due to inter- and intra-breath-hold variations. We assess robustness and dosimetric plan quality of robust optimized (RO)-DYMBARC under DIBH variations with comparison to VMAT. Materials and Methods: Ten cases were created using the XCAT anthropomorphic phantom. NiftyReg was used to obtain deformation vector fields (DVFs) for DIBH variations. For each case, three plans were created: PTV-based VMAT, RO-VMAT, and RO-DYMBARC, prescribed 42.4 Gy to the target volume (PTV or CTV for RO plans). Robustness to DIBH variations was assessed by recalculating doses using the DVFs and deformable voxel geometry Monte Carlo simulations. Dosimetric endpoints for targets and organs at risk (OARs) were compared using Wilcoxon matched-pair signed-rank test (α=0.05). Results: RO-DYMBARC demonstrated significantly better OAR sparing compared to VMAT, with mean dose to heart and contralateral breast up to 1 Gy lower than PTV-based VMAT. Target coverage and robustness to DIBH variations were similar across all plans. For OARs, DIBH variations led to dose differences ≤ 0.1 Gy for all plans and endpoints compared to the nominal scenario. Conclusion: RO-DYMBARC provided superior dosimetric plan quality with similar robustness to DIBH variations compared to VMAT. The dosimetric advantage of RO-DYMBARC was maintained in the presence of DIBH variations.
- Open Access
- 26 October 2024
- Published by Wiley in Medical Physics
- Vol. 52 (1) , 489-503
Dosimetric optimization for dynamic mixed beam arc therapy (DYMBARC)
Background: Non‐coplanarity and mixed beam modality could be combined to further enhance dosimetric treatment plan quality. We introduce dynamic mixed beam arc therapy (DYMBARC) as an innovative technique that combines non‐coplanar photon and electron arcs, dynamic gantry and collimator rotations, and intensity modulation with photon multileaf collimator (MLC). However, finding favorable beam directions for DYMBARC is challenging due to the large solution space, machine component constraints, and optimization parameters, posing a highly non‐convex optimization problem.Purpose: To establish DYMBARC and solve the pathfinding challenge by employing direct aperture optimization (DAO) to determine the table angles and gantry angle ranges of photon and electron arcs for different clinically motivated cases.Methods: The method starts by generating a grid of beam directions based on user‐defined resolutions along the gantry and table angle axes for each beam quality considered. Beam directions causing collisions or entering through the end of CT are excluded. For electrons, a fixed source‐to‐surface distance of 80 cm is used to reduce in‐air scatter. Electron beam energies with insufficient range to reach the target or beam directions impinging on the table before reaching the patient are excluded. The remaining beam directions form the pathfinding solution space. Promising photon and electron MLC‐defined apertures, with associated monitor unit (MU) weights, are iteratively added using a hybrid‐DAO algorithm. This algorithm combines column generation to add apertures and simulated annealing to further refine aperture shapes and weights. Apertures are added until the requested number of paths are formed and the user‐defined maximum total gantry angle range is reached. Paths are resampled to a finer gantry angle resolution and subject to DAO for simultaneous optimization of beam intensities along the photon/electron arcs. Subsequent final dose calculation and MU weight reoptimization result in a deliverable DYMBARC plan. DYMBARC plans are created for three clinically motivated cases (brain, breast, and pelvis) and compared to DYMBARC variants: colli‐DTRT (dynamic collimator trajectory radiotherapy) using non‐coplanar photon arcs; and Arc‐MBRT (mixed beam radiotherapy) using photons and electrons but restricted to coplanar setup. Additionally, a manually defined volumetric modulated arc therapy (VMAT) setup serves as a reference clinical technique. Dose distributions, dose‐volume histograms, and dosimetric endpoints are evaluated. Dosimetric validation with radiochromic film measurements (gamma evaluation, 3% / 2 mm (global), 10% dose threshold) is performed on a TrueBeam system in developer mode for one case.Results: While maintaining similar target coverage and homogeneity, DYMBARC reduced mean doses to organs‐at‐risk compared to VMAT by an average of 3.2, 0.5, and 2.9 Gy for the brain, breast, and pelvis cases, respectively. Similar or smaller mean dose reductions were observed for Arc‐MBRT or colli‐DTRT, compared to VMAT. Electron contributions to the mean planning target volume dose ranged from 2% to 34% for DYMBARC and from 11% to 40% for Arc‐MBRT. Measurement validation showed >99.7% gamma passing rate.Conclusions: DYMBARC was successfully established using a dosimetrically optimized pathfinding approach, combining non‐coplanarity with mixed beam modality. DYMBARC facilitated the determination of photon and electron contributions on a case‐by‐case basis, enhancing more personalized treatment modalities.
- 26 October 2024
- Published by Wiley in Medical Physics
- Vol. 52 (1) , 489-503
Open AccessDosimetric optimization for dynamic mixed beam arc therapy (DYMBARC)
Background: Non‐coplanarity and mixed beam modality could be combined to further enhance dosimetric treatment plan quality. We introduce dynamic mixed beam arc therapy (DYMBARC) as an innovative technique that combines non‐coplanar photon and electron arcs, dynamic gantry and collimator rotations, and intensity modulation with photon multileaf collimator (MLC). However, finding favorable beam directions for DYMBARC is challenging due to the large solution space, machine component constraints, and optimization parameters, posing a highly non‐convex optimization problem.Purpose: To establish DYMBARC and solve the pathfinding challenge by employing direct aperture optimization (DAO) to determine the table angles and gantry angle ranges of photon and electron arcs for different clinically motivated cases.Methods: The method starts by generating a grid of beam directions based on user‐defined resolutions along the gantry and table angle axes for each beam quality considered. Beam directions causing collisions or entering through the end of CT are excluded. For electrons, a fixed source‐to‐surface distance of 80 cm is used to reduce in‐air scatter. Electron beam energies with insufficient range to reach the target or beam directions impinging on the table before reaching the patient are excluded. The remaining beam directions form the pathfinding solution space. Promising photon and electron MLC‐defined apertures, with associated monitor unit (MU) weights, are iteratively added using a hybrid‐DAO algorithm. This algorithm combines column generation to add apertures and simulated annealing to further refine aperture shapes and weights. Apertures are added until the requested number of paths are formed and the user‐defined maximum total gantry angle range is reached. Paths are resampled to a finer gantry angle resolution and subject to DAO for simultaneous optimization of beam intensities along the photon/electron arcs. Subsequent final dose calculation and MU weight reoptimization result in a deliverable DYMBARC plan. DYMBARC plans are created for three clinically motivated cases (brain, breast, and pelvis) and compared to DYMBARC variants: colli‐DTRT (dynamic collimator trajectory radiotherapy) using non‐coplanar photon arcs; and Arc‐MBRT (mixed beam radiotherapy) using photons and electrons but restricted to coplanar setup. Additionally, a manually defined volumetric modulated arc therapy (VMAT) setup serves as a reference clinical technique. Dose distributions, dose‐volume histograms, and dosimetric endpoints are evaluated. Dosimetric validation with radiochromic film measurements (gamma evaluation, 3% / 2 mm (global), 10% dose threshold) is performed on a TrueBeam system in developer mode for one case.Results: While maintaining similar target coverage and homogeneity, DYMBARC reduced mean doses to organs‐at‐risk compared to VMAT by an average of 3.2, 0.5, and 2.9 Gy for the brain, breast, and pelvis cases, respectively. Similar or smaller mean dose reductions were observed for Arc‐MBRT or colli‐DTRT, compared to VMAT. Electron contributions to the mean planning target volume dose ranged from 2% to 34% for DYMBARC and from 11% to 40% for Arc‐MBRT. Measurement validation showed >99.7% gamma passing rate.Conclusions: DYMBARC was successfully established using a dosimetrically optimized pathfinding approach, combining non‐coplanarity with mixed beam modality. DYMBARC facilitated the determination of photon and electron contributions on a case‐by‐case basis, enhancing more personalized treatment modalities.
- Open Access
- 22 October 2024
- Published by Wiley in Medical Physics
- Vol. 52 (2) , 1281-1292
Monte Carlo dose calculation for photon and electron radiotherapy on dynamically deforming anatomy
Background: Dose calculation in radiotherapy aims to accurately estimate and assess the dose distribution of a treatment plan. Monte Carlo (MC) dose calculation is considered the gold standard owing to its ability to accurately simulate particle transport in inhomogeneous media. However, uncertainties such as the patient's dynamically deforming anatomy can still lead to differences between the delivered and planned dose distribution.Purpose: Development and validation of a deformable voxel geometry for MC dose calculations (DefVoxMC) to account for dynamic deformation in the dose calculation process of photon‐ and electron‐based radiotherapy treatment plans for clinically motivated cases.Methods: DefVoxMC relies on the subdivision of a regular voxel geometry into dodecahedrons. It allows shifting the dodecahedrons’ corner points according to the deformation in the patient's anatomy using deformation vector fields (DVF). DefVoxMC is integrated into the Swiss Monte Carlo Plan (SMCP) to allow the MC dose calculation of photon‐ and electron‐based treatment plans on the deformable voxel geometry. DefVoxMC is validated in two steps. A compression test and a Fano test are performed in silico. Delta4 (for photon beams) and EBT4 film measurements in a cubic PMMA phantom (for electron beams) are performed on a TrueBeam in Developer Mode for clinically motivated treatment plans. During these measurements, table motion is used to mimic rigid dynamic patient motion. The measured and calculated dose distributions are compared using gamma passing rate (GPR) (3% / 2 mm (global), 10% threshold). DefVoxMC is used to study the impact of patient‐recorded breathing motion on the dose distribution for clinically motivated lung and breast cases, each prescribed 50 Gy to 50% of the target volume. A volumetric modulated arc therapy (VMAT) and an arc mixed‐beam radiotherapy (Arc‐MBRT) plan are created for the lung and breast case, respectively. For the dose calculation, the dynamic deformation of the patient's anatomy is described by DVFs obtained from deformable image registration of the different phases of 4DCTs. The resulting dose distributions are compared to the ones of the static situation using dose–volume histograms and dose differences.Results: DefVoxMC is successfully integrated into the SMCP to enable the MC dose calculation of photon‐ and electron‐based treatments on a dynamically deforming patient anatomy. The compression and the Fano test agree within 1.0% and 0.1% with the expected result, respectively. Delta4 and EBT4 film measurements agree with the calculated dose by a GPR >95%. For the clinically motivated cases, breathing motion resulted in areas with a dose increase of up to 26.9 Gy (lung) and up to 7.6 Gy (breast) compared to the static situation. The largest dose differences are observed in high‐dose‐gradient regions perpendicular to the beam plane, consequently decreasing the planning target volume coverage (V95%) by 4.2% for the lung case and 2.0% for the breast case.Conclusions: A novel method for MC dose calculation for photon‐ and electron‐based treatments on dynamically deforming anatomy is successfully developed and validated. Applying DefVoxMC to clinically motivated cases, we found that breathing motion has non‐negligible impact on the dosimetric plan quality.
- 22 October 2024
- Published by Wiley in Medical Physics
- Vol. 52 (2) , 1281-1292
Open AccessMonte Carlo dose calculation for photon and electron radiotherapy on dynamically deforming anatomy
Background: Dose calculation in radiotherapy aims to accurately estimate and assess the dose distribution of a treatment plan. Monte Carlo (MC) dose calculation is considered the gold standard owing to its ability to accurately simulate particle transport in inhomogeneous media. However, uncertainties such as the patient's dynamically deforming anatomy can still lead to differences between the delivered and planned dose distribution.Purpose: Development and validation of a deformable voxel geometry for MC dose calculations (DefVoxMC) to account for dynamic deformation in the dose calculation process of photon‐ and electron‐based radiotherapy treatment plans for clinically motivated cases.Methods: DefVoxMC relies on the subdivision of a regular voxel geometry into dodecahedrons. It allows shifting the dodecahedrons’ corner points according to the deformation in the patient's anatomy using deformation vector fields (DVF). DefVoxMC is integrated into the Swiss Monte Carlo Plan (SMCP) to allow the MC dose calculation of photon‐ and electron‐based treatment plans on the deformable voxel geometry. DefVoxMC is validated in two steps. A compression test and a Fano test are performed in silico. Delta4 (for photon beams) and EBT4 film measurements in a cubic PMMA phantom (for electron beams) are performed on a TrueBeam in Developer Mode for clinically motivated treatment plans. During these measurements, table motion is used to mimic rigid dynamic patient motion. The measured and calculated dose distributions are compared using gamma passing rate (GPR) (3% / 2 mm (global), 10% threshold). DefVoxMC is used to study the impact of patient‐recorded breathing motion on the dose distribution for clinically motivated lung and breast cases, each prescribed 50 Gy to 50% of the target volume. A volumetric modulated arc therapy (VMAT) and an arc mixed‐beam radiotherapy (Arc‐MBRT) plan are created for the lung and breast case, respectively. For the dose calculation, the dynamic deformation of the patient's anatomy is described by DVFs obtained from deformable image registration of the different phases of 4DCTs. The resulting dose distributions are compared to the ones of the static situation using dose–volume histograms and dose differences.Results: DefVoxMC is successfully integrated into the SMCP to enable the MC dose calculation of photon‐ and electron‐based treatments on a dynamically deforming patient anatomy. The compression and the Fano test agree within 1.0% and 0.1% with the expected result, respectively. Delta4 and EBT4 film measurements agree with the calculated dose by a GPR >95%. For the clinically motivated cases, breathing motion resulted in areas with a dose increase of up to 26.9 Gy (lung) and up to 7.6 Gy (breast) compared to the static situation. The largest dose differences are observed in high‐dose‐gradient regions perpendicular to the beam plane, consequently decreasing the planning target volume coverage (V95%) by 4.2% for the lung case and 2.0% for the breast case.Conclusions: A novel method for MC dose calculation for photon‐ and electron‐based treatments on dynamically deforming anatomy is successfully developed and validated. Applying DefVoxMC to clinically motivated cases, we found that breathing motion has non‐negligible impact on the dosimetric plan quality.
- Open Access
- 26 October 2023
- Published by IOP Publishing in Physics in Medicine & Biology
- Vol. 68 (21) , 215009
Delivery time reduction for mixed photon-electron radiotherapy by using photon MLC collimated electron arcs
Objective . Electron arcs in mixed-beam radiotherapy (Arc-MBRT) consisting of intensity-modulated electron arcs with dynamic gantry rotation potentially reduce the delivery time compared to mixed-beam radiotherapy containing electron beams with static gantry angle (Static-MBRT). This study aims to develop and investigate a treatment planning process (TPP) for photon multileaf collimator (pMLC) based Arc-MBRT. Approach . An existing TPP for Static-MBRT plans is extended to integrate electron arcs with a dynamic gantry rotation and intensity modulation using a sliding window technique. The TPP consists of a manual setup of electron arcs, and either static photon beams or photon arcs, shortening of the source-to-surface distance for the electron arcs, initial intensity modulation optimization, selection of a user-defined number of electron beam energies based on dose contribution to the target volume and finally, simultaneous photon and electron intensity modulation optimization followed by full Monte Carlo dose calculation. Arc-MBRT plans, Static-MBRT plans, and photon-only plans were created and compared for four breast cases. Dosimetric validation of two Arc-MBRT plans was performed using film measurements. Main results . The generated Arc-MBRT plans are dosimetrically similar to the Static-MBRT plans while outperforming the photon-only plans. The mean heart dose is reduced by 32% on average in the MBRT plans compared to the photon-only plans. The estimated delivery times of the Arc-MBRT plans are similar to the photon-only plans but less than half the time of the Static-MBRT plans. Measured and calculated dose distributions agree with a gamma passing rate of over 98% (3% global, 2 mm) for both delivered Arc-MBRT plans. Significance . A TPP for Arc-MBRT is successfully developed and Arc-MBRT plans showed the potential to improve the dosimetric plan quality similar as Static-MBRT while maintaining short delivery times of photon-only treatments. This further facilitates integration of pMLC-based MBRT into clinical practice.
- 26 October 2023
- Published by IOP Publishing in Physics in Medicine & Biology
- Vol. 68 (21) , 215009
Open AccessDelivery time reduction for mixed photon-electron radiotherapy by using photon MLC collimated electron arcs
Objective . Electron arcs in mixed-beam radiotherapy (Arc-MBRT) consisting of intensity-modulated electron arcs with dynamic gantry rotation potentially reduce the delivery time compared to mixed-beam radiotherapy containing electron beams with static gantry angle (Static-MBRT). This study aims to develop and investigate a treatment planning process (TPP) for photon multileaf collimator (pMLC) based Arc-MBRT. Approach . An existing TPP for Static-MBRT plans is extended to integrate electron arcs with a dynamic gantry rotation and intensity modulation using a sliding window technique. The TPP consists of a manual setup of electron arcs, and either static photon beams or photon arcs, shortening of the source-to-surface distance for the electron arcs, initial intensity modulation optimization, selection of a user-defined number of electron beam energies based on dose contribution to the target volume and finally, simultaneous photon and electron intensity modulation optimization followed by full Monte Carlo dose calculation. Arc-MBRT plans, Static-MBRT plans, and photon-only plans were created and compared for four breast cases. Dosimetric validation of two Arc-MBRT plans was performed using film measurements. Main results . The generated Arc-MBRT plans are dosimetrically similar to the Static-MBRT plans while outperforming the photon-only plans. The mean heart dose is reduced by 32% on average in the MBRT plans compared to the photon-only plans. The estimated delivery times of the Arc-MBRT plans are similar to the photon-only plans but less than half the time of the Static-MBRT plans. Measured and calculated dose distributions agree with a gamma passing rate of over 98% (3% global, 2 mm) for both delivered Arc-MBRT plans. Significance . A TPP for Arc-MBRT is successfully developed and Arc-MBRT plans showed the potential to improve the dosimetric plan quality similar as Static-MBRT while maintaining short delivery times of photon-only treatments. This further facilitates integration of pMLC-based MBRT into clinical practice.
- Open Access
- 2 October 2023
- Published by Wiley in Journal of Applied Clinical Medical Physics
- Vol. 24 (11) , e14165
Technical note: A collision prediction tool using Blender
Non‐coplanar radiotherapy treatment techniques on C‐arm linear accelerators have the potential to reduce dose to organs‐at‐risk in comparison with coplanar treatment techniques. Accurately predicting possible collisions between gantry, table and patient during treatment planning is needed to ensure patient safety. We offer a freely available collision prediction tool using Blender, a free and open‐source 3D computer graphics software toolset. A geometric model of a C‐arm linear accelerator including a library of patient models is created inside Blender. Based on the model, collision predictions can be used both to calculate collision‐free zones and to check treatment plans for collisions. The tool is validated for two setups, once with and once without a full body phantom with the same table position. For this, each gantry‐table angle combination with a 2° resolution is manually checked for collision interlocks at a TrueBeam system and compared to simulated collision predictions. For the collision check of a treatment plan, the tool outputs the minimal distance between the gantry, table and patient model and a video of the movement of the gantry and table, which is demonstrated for one use case. A graphical user interface allows user‐friendly input of the table and patient specification for the collision prediction tool. The validation resulted in a true positive rate of 100%, which is the rate between the number of correctly predicted collision gantry‐table combinations and the number of all measured collision gantry‐table combinations, and a true negative rate of 89%, which is the ratio between the number of correctly predicted collision‐free combinations and the number of all measured collision‐free combinations. A collision prediction tool is successfully created and able to produce maps of collision‐free zones and to test treatment plans for collisions including visualisation of the gantry and table movement.
- 2 October 2023
- Published by Wiley in Journal of Applied Clinical Medical Physics
- Vol. 24 (11) , e14165
Open AccessTechnical note: A collision prediction tool using Blender
Non‐coplanar radiotherapy treatment techniques on C‐arm linear accelerators have the potential to reduce dose to organs‐at‐risk in comparison with coplanar treatment techniques. Accurately predicting possible collisions between gantry, table and patient during treatment planning is needed to ensure patient safety. We offer a freely available collision prediction tool using Blender, a free and open‐source 3D computer graphics software toolset. A geometric model of a C‐arm linear accelerator including a library of patient models is created inside Blender. Based on the model, collision predictions can be used both to calculate collision‐free zones and to check treatment plans for collisions. The tool is validated for two setups, once with and once without a full body phantom with the same table position. For this, each gantry‐table angle combination with a 2° resolution is manually checked for collision interlocks at a TrueBeam system and compared to simulated collision predictions. For the collision check of a treatment plan, the tool outputs the minimal distance between the gantry, table and patient model and a video of the movement of the gantry and table, which is demonstrated for one use case. A graphical user interface allows user‐friendly input of the table and patient specification for the collision prediction tool. The validation resulted in a true positive rate of 100%, which is the rate between the number of correctly predicted collision gantry‐table combinations and the number of all measured collision gantry‐table combinations, and a true negative rate of 89%, which is the ratio between the number of correctly predicted collision‐free combinations and the number of all measured collision‐free combinations. A collision prediction tool is successfully created and able to produce maps of collision‐free zones and to test treatment plans for collisions including visualisation of the gantry and table movement.
- Open Access
- 29 September 2023
- Published by Elsevier in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
- Vol. 117 (2) , e644
Comparison of Dynamic Trajectory Radiotherapy and Volumetric Modulated Arc Therapy for Loco-Regionally Advanced Oropharyngeal Cancer
- 29 September 2023
- Published by Elsevier in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
- Vol. 117 (2) , e644
Open AccessComparison of Dynamic Trajectory Radiotherapy and Volumetric Modulated Arc Therapy for Loco-Regionally Advanced Oropharyngeal Cancer
- Open Access
- 25 September 2023
- Published by Wiley in Medical Physics
- Vol. 50 (11) , 7104-7117
Impact of the gradient in gantry‐table rotation on dynamic trajectory radiotherapy plan quality
Background: To improve organ at risk (OAR) sparing, dynamic trajectory radiotherapy (DTRT) extends VMAT by dynamic table and collimator rotation during beam‐on. However, comprehensive investigations regarding the impact of the gantry‐table (GT) rotation gradient on the DTRT plan quality have not been conducted.Purpose: To investigate the impact of a user‐defined GT rotation gradient on plan quality of DTRT plans in terms of dosimetric plan quality, dosimetric robustness, deliverability, and delivery time.Methods: The dynamic trajectories of DTRT are described by GT and gantry‐collimator paths. The GT path is determined by minimizing the overlap of OARs with planning target volume (PTV). This approach is extended to consider a GT rotation gradient by means of a maximum gradient of the path () between two adjacent control points () and maximum absolute change of G (). Four DTRT plans are created with different maximum G&∆G: & = 0.5&0.125 (DTRT‐1), 1&0.125 (DTRT‐2), 3&0.125 (DTRT‐3) and 3&1(DTRT‐4), including 3–4 dynamic trajectories, for three clinically motivated cases in the head and neck and brain region (A, B, and C). A reference VMAT plan for each case is created. For all plans, plan quality is assessed and compared. Dosimetric plan quality is evaluated by target coverage, conformity, and OAR sparing. Dosimetric robustness is evaluated against systematic and random patient‐setup uncertainties between in the lateral, longitudinal, and vertical directions, and machine uncertainties between in the dynamically rotating machine components (gantry, table, collimator rotation). Delivery time is recorded. Deliverability and delivery accuracy on a TrueBeam are assessed by logfile analysis for all plans and additionally verified by film measurements for one case. All dose calculations are Monte Carlo based.Results: The extension of the DTRT planning process with user‐defined to investigate the impact of the GT rotation gradient on plan quality is successfully demonstrated. With increasing , slight (case C, : up to−1Gy) and substantial (case A, : up to −9.3 Gy, caseB,: up to −4.7Gy) improvements in OAR sparing are observed compared to VMAT, while maintaining similar target coverage. All plans are delivered on the TrueBeam. Expected and actual machine position values recorded in the logfiles deviated by 96% (2%global/2 mm Gamma passing rate) with the dose calculation. With increasing , delivery time is prolonged by <2 min/trajectory (DTRT‐4) compared to VMAT and DTRT‐1. The DTRT plans for case A and B and the VMAT plan for case C plan reveal the best dosimetric robustness for the considered uncertainties.Conclusion: The impact of the GT rotation gradient on DTRT plan quality is comprehensively investigated for three cases in the head and neck and brain region. Increasing freedom in this gradient improves dosimetric plan quality at the cost of increased delivery time for the investigated cases. No clear dependency of GT rotation gradient on dosimetric robustness is observed.
- 25 September 2023
- Published by Wiley in Medical Physics
- Vol. 50 (11) , 7104-7117
Open AccessImpact of the gradient in gantry‐table rotation on dynamic trajectory radiotherapy plan quality
Background: To improve organ at risk (OAR) sparing, dynamic trajectory radiotherapy (DTRT) extends VMAT by dynamic table and collimator rotation during beam‐on. However, comprehensive investigations regarding the impact of the gantry‐table (GT) rotation gradient on the DTRT plan quality have not been conducted.Purpose: To investigate the impact of a user‐defined GT rotation gradient on plan quality of DTRT plans in terms of dosimetric plan quality, dosimetric robustness, deliverability, and delivery time.Methods: The dynamic trajectories of DTRT are described by GT and gantry‐collimator paths. The GT path is determined by minimizing the overlap of OARs with planning target volume (PTV). This approach is extended to consider a GT rotation gradient by means of a maximum gradient of the path () between two adjacent control points () and maximum absolute change of G (). Four DTRT plans are created with different maximum G&∆G: & = 0.5&0.125 (DTRT‐1), 1&0.125 (DTRT‐2), 3&0.125 (DTRT‐3) and 3&1(DTRT‐4), including 3–4 dynamic trajectories, for three clinically motivated cases in the head and neck and brain region (A, B, and C). A reference VMAT plan for each case is created. For all plans, plan quality is assessed and compared. Dosimetric plan quality is evaluated by target coverage, conformity, and OAR sparing. Dosimetric robustness is evaluated against systematic and random patient‐setup uncertainties between in the lateral, longitudinal, and vertical directions, and machine uncertainties between in the dynamically rotating machine components (gantry, table, collimator rotation). Delivery time is recorded. Deliverability and delivery accuracy on a TrueBeam are assessed by logfile analysis for all plans and additionally verified by film measurements for one case. All dose calculations are Monte Carlo based.Results: The extension of the DTRT planning process with user‐defined to investigate the impact of the GT rotation gradient on plan quality is successfully demonstrated. With increasing , slight (case C, : up to−1Gy) and substantial (case A, : up to −9.3 Gy, caseB,: up to −4.7Gy) improvements in OAR sparing are observed compared to VMAT, while maintaining similar target coverage. All plans are delivered on the TrueBeam. Expected and actual machine position values recorded in the logfiles deviated by 96% (2%global/2 mm Gamma passing rate) with the dose calculation. With increasing , delivery time is prolonged by <2 min/trajectory (DTRT‐4) compared to VMAT and DTRT‐1. The DTRT plans for case A and B and the VMAT plan for case C plan reveal the best dosimetric robustness for the considered uncertainties.Conclusion: The impact of the GT rotation gradient on DTRT plan quality is comprehensively investigated for three cases in the head and neck and brain region. Increasing freedom in this gradient improves dosimetric plan quality at the cost of increased delivery time for the investigated cases. No clear dependency of GT rotation gradient on dosimetric robustness is observed.
- 24 July 2023
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 182, S826-S827
PD-0978 Electron modulated arc therapy for breast boost: development of a treatment planning process
- 24 July 2023
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 182, S826-S827
PD-0978 Electron modulated arc therapy for breast boost: development of a treatment planning process
- 24 July 2023
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 182, S509-S511
OC-0621 Dosimetric beam-angle optimization for non-coplanar dynamic-collimator trajectory radiotherapy
- 24 July 2023
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 182, S509-S511
OC-0621 Dosimetric beam-angle optimization for non-coplanar dynamic-collimator trajectory radiotherapy
- 24 July 2023
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 182, S265-S266
PD-0331 Automated dynamic trajectory radiotherapy planning using 4pi-IMRT path-finding - proof of concept
- 24 July 2023
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 182, S265-S266
PD-0331 Automated dynamic trajectory radiotherapy planning using 4pi-IMRT path-finding - proof of concept